VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-01284 Package ID: USCOURTS-cofc-1_18-vv-01284 Petitioner: Dolores Gorczyca Filed: 2018-08-24 Decided: 2020-04-30 Vaccine: influenza Vaccination date: 2017-10-03 Condition: Guillain-Barré Syndrome (GBS) Outcome: compensated Award amount USD: 174100 AI-assisted case summary: Dolores Gorczyca filed a petition for compensation under the National Vaccine Injury Compensation Program on August 24, 2018, alleging that she developed Guillain-Barré Syndrome (GBS) as a result of an influenza vaccination administered on October 3, 2017. The respondent, represented by Debra A. Filteau Begley of the U.S. Department of Justice, filed a Rule 4(c) report conceding that Ms. Gorczyca's claim met the criteria for a Table injury for GBS. The respondent further agreed that her condition had persisted for at least six months and that there was no alternative cause for her condition. On August 13, 2019, Chief Special Master Nora Beth Dorsey issued a ruling on entitlement, finding Ms. Gorczyca entitled to compensation. Subsequently, on March 27, 2020, the respondent filed a proffer on award of compensation. The proffer recommended a total award of $174,100.00, consisting of $170,000.00 for pain and suffering and $4,100.00 for past out-of-pocket medical expenses. Ms. Gorczyca, who is a competent adult and represented by Nancy Routh Meyers of Ward Black Law (later Turning Point Litigation), agreed with the proffered award. On April 30, 2020, Chief Special Master Brian H. Corcoran issued a decision awarding Ms. Gorczyca the lump sum of $174,100.00, payable by check to her. The public decision does not describe the onset of symptoms, specific medical tests, treatments, or the mechanism of causation beyond its classification as a Table injury. Theory of causation field: Petitioner Dolores Gorczyca alleged that an influenza vaccine administered on October 3, 2017, caused her to develop Guillain-Barré Syndrome (GBS). The respondent conceded that the claim met the criteria for a Table injury for GBS, satisfying the requirements of the National Vaccine Injury Compensation Program. The respondent's Rule 4(c) report, filed August 12, 2019, stated that the petitioner's condition persisted for at least six months and had no alternative cause. Chief Special Master Nora Beth Dorsey issued a ruling on entitlement on August 13, 2019, finding the petitioner entitled to compensation. On March 27, 2020, respondent filed a proffer on award of compensation, recommending $174,100.00 ($170,000.00 for pain and suffering, $4,100.00 for past out-of-pocket medical expenses), which the petitioner agreed to. Chief Special Master Brian H. Corcoran issued a decision awarding this amount on April 30, 2020. Petitioner was represented by Nancy Routh Meyers (Ward Black Law/Turning Point Litigation), and respondent was represented by Debra A. Filteau Begley (U.S. Department of Justice). Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_18-vv-01284-0 Date issued/filed: 2019-11-08 Pages: 2 Docket text: PUBLIC ORDER/RULING (Originally filed: 8/13/2019) regarding 28 Ruling on Entitlement Signed by Special Master Nora Beth Dorsey. (ypb) Service on parties made. -------------------------------------------------------------------------------- Case 1:18-vv-01284-UNJ Document 35 Filed 11/08/19 Page 1 of 2 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-1284V Filed: August 13, 2019 UNPUBLISHED DOLORES GORCZYCA, Petitioner, Special Processing Unit (SPU); v. Ruling on Entitlement; Concession; Table Injury; Influenza (Flu) Vaccine; SECRETARY OF HEALTH AND Guillain-Barre Syndrome (GBS) HUMAN SERVICES, Respondent. Nancy Routh Meyers, Ward Black Law, Greensboro, NC, for petitioner. Debra A. Filteau Begley, U.S. Department of Justice, Washington, DC, for respondent. RULING ON ENTITLEMENT1 Dorsey, Chief Special Master: On August 24, 2018, petitioner filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that as a result of an influenza (“flu”) vaccination administered on October 3, 2017, she developed Guillain-Barré Syndrome (“GBS”). Petition at 1. The case was assigned to the Special Processing Unit of the Office of Special Masters. 1 The undersigned intends to post this ruling on the United States Court of Federal Claims' website. This means the ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. Because this unpublished ruling contains a reasoned explanation for the action in this case, undersigned is required to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:18-vv-01284-UNJ Document 35 Filed 11/08/19 Page 2 of 2 On August 12, 2019, respondent filed his Rule 4(c) report in which he concedes that petitioner is entitled to compensation in this case. Respondent’s Rule 4(c) Report at 1. Specifically, “it is respondent’s position that petitioner has satisfied the criteria set forth in the Vaccine Injury Table (“Table”) and the Qualifications and Aids to Interpretation for a flu/GBS Table injury.” Id. at 6. Respondent further agrees that “petitioner’s condition has persisted for at least six months, and there is no alternative cause that explains her condition.” Id. In view of respondent’s position and the evidence of record, the undersigned finds that petitioner is entitled to compensation. IT IS SO ORDERED. s/Nora Beth Dorsey Nora Beth Dorsey Chief Special Master 2 ================================================================================ DOCUMENT 2: USCOURTS-cofc-1_18-vv-01284-1 Date issued/filed: 2020-04-30 Pages: 4 Docket text: PUBLIC DECISION (Originally filed: 03/30/2020) regarding 48 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made. -------------------------------------------------------------------------------- Case 1:18-vv-01284-UNJ Document 52 Filed 04/30/20 Page 1 of 4 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-1284V UNPUBLISHED DOLORES GORCZYCA, Chief Special Master Corcoran Petitioner, Filed: March 30, 2020 v. Special Processing Unit (SPU); SECRETARY OF HEALTH AND Damages Decision Based on Proffer; HUMAN SERVICES, Influenza (Flu) Vaccine; Guillain- Barre Syndrome (GBS) Respondent. Nancy Routh Meyers, Turning Point Litigation, Greensboro, NC, for petitioner. Debra A. Filteau Begley, U.S. Department of Justice, Washington, DC, for respondent. DECISION AWARDING DAMAGES1 On August 24, 2018, Dolores Gorczyca filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that as a result of an influenza (“flu”) vaccination administered on October 3, 2017, she suffered Guillain-Barré syndrome (“GBS”). Petition at 1. The case was assigned to the Special Processing Unit of the Office of Special Masters. On August 13, 2019, a ruling on entitlement was issued, finding Petitioner entitled to compensation for GBS. On March 27, 2020, Respondent filed a proffer on award of compensation (“Proffer”) indicating Petitioner should be awarded $174,100.00, representing $170,000.00 for pain and suffering and $4,100.00 for past out-of-pocket medical expenses. Proffer at 1. In the Proffer, Respondent represented that Petitioner 1 Because this unpublished decision contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:18-vv-01284-UNJ Document 52 Filed 04/30/20 Page 2 of 4 agrees with the proffered award. Id. Based on the record as a whole, I find that Petitioner is entitled to an award as stated in the Proffer. Pursuant to the terms stated in the attached Proffer, I award Petitioner a lump sum payment of $174,100.00, which represents $170,000.00 for pain and suffering and $4,100.00 for past out-of-pocket medical expenses in the form of a check payable to Petitioner. This amount represents compensation for all damages that would be available under § 15(a). The clerk of the court is directed to enter judgment in accordance with this decision.3 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:18-vv-01284-UNJ Document 52 Filed 04/30/20 Page 3 of 4 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS ************************************* DOLORES GORCZYCA, * * Petitioner, * No. 18-1284V * Chief Special Master Corcoran v. * * SECRETARY OF HEALTH AND * HUMAN SERVICES, * * Respondent. * ************************************* RESPONDENT’S PROFFER ON AWARD OF COMPENSATION On August 13, 2019, respondent filed a Rule 4(c) Report, conceding that petitioner’s claim meets the Table criteria for Guillain-Barré Syndrome (“GBS”) injury. On that same day, the Court issued a Ruling on Entitlement finding petitioner entitled to compensation under the Vaccine Act. I. Items of Compensation Based upon the evidence of record, respondent proffers that petitioner should be awarded the following, and requests that the Chief Special Master’s decision and the Court’s judgment award: 1. A lump sum payment of $170,000.00, which represents compensation for pain and suffering, see 42 U.S.C. § 300aa-15(a)(4); and 2. A payment of $4,100.00, which represents compensation for past out-of-pocket medical expenses, see 42 U.S.C. § 300aa-15(a)(1). Case 1:18-vv-01284-UNJ Document 52 Filed 04/30/20 Page 4 of 4 These amounts represent all elements of compensation to which petitioner would be entitled under 42 U.S.C. § 300aa-15(a).1 Petitioner agrees. II. Form of the Award Petitioner is a competent adult. Evidence of guardianship is not required in this case. Respondent recommends that petitioner be awarded a lump sum payment of $174,100.00, in the form of a check payable to petitioner. Petitioner agrees. Respectfully submitted, JOSEPH H. HUNT Assistant Attorney General C. SALVATORE D’ALESSIO Acting Director Torts Branch, Civil Division CATHARINE E. REEVES Deputy Director Torts Branch, Civil Division ALEXIS B. BABCOCK Assistant Director Torts Branch, Civil Division /s/ DEBRA A. FILTEAU BEGLEY DEBRA A. FILTEAU BEGLEY Senior Trial Attorney Torts Branch, Civil Division U.S. Department of Justice P.O. Box 146 Benjamin Franklin Station Washington, D.C. 20044-0146 Phone: (202) 616-4181 Dated: March 27, 2020 1 Should petitioner die prior to the entry of judgment, the parties reserve the right to move the Court for appropriate relief. In particular, respondent would oppose any award for future pain and suffering. 2